
Three years ago, Johan, Oliver, Philipp, and Reudi made a commitment to extent the promising proteomics technology they developed at ETH Zurich to industry and academia. Thus, Biognosys was formed, and since then, companies and researchers from different continents searching for treatments to disease, better diagnostic tools, improved sources of renewable energy, enhanced crop production, etc. have benefited from this mission. Biognosys would like to thank the many customers, collaborators, and investors who have shared our vision for the last three years and continue with us to provide next generation proteomics in the future.
Prost!
Need a new RT-Kit?
See our offers here.